Evaluating the role of IL-11, a novel cytokine in the IL-6 family, in a mouse model of spinal cord injury

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Cho, Newton ^a   Nguyen, Dung H ^a   Satkunendrarajah, Kajana ^a   Branch, Donald R ^c   Fehlings, Michael G ^a,b,d  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Electrophysiology; Gp130 receptor; Il 11; Immune response; Locomotor recovery; Mouse model; Spinal cord injury

Indexed keywords

INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR ALPHA; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; EVOKED RESPONSE; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; INTERLEUKIN 11 GENE; INTERLEUKIN 11 RECEPTOR ALPHA GENE; KNOCKOUT MOUSE; LOCOMOTION; MOTOR PERFORMANCE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; WILD TYPE;

EID: 84862311781     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-134     Document Type: Article

References (31)

1. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008, 25:1-17.
2. Gál P, Kravčuková P, Mokrý M, Kluchová D. Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review. Cell Mol Neurobiol 2009, 29:1025-1035. 10.1007/s10571-009-9392-4, 19363652.
3. Alexander JK, Popovich PG. Neuroinflammation in spinal cord injury: Therapeutic targets for neuroprotection and regeneration. Prog Brain Res 2009, 175:125-137.
4. Ito Y, Sugimoto Y, Tomioka M, Kai N, Takana M. Does high dose methylprednisolone sodium succinate really improve neurological status in patient with acute cervical spinal cord injury?. Spine 2009, 34:2121-2124. 10.1097/BRS.0b013e3181b613c7, 19713878.
5. Baptiste DC, Fehlings MG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma 2006, 23:318-334. 10.1089/neu.2006.23.318, 16629619.
6. Hibi M, Nakajima K, Hirano I. IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 1996, 74:1-12. 10.1007/BF00202068, 8834766.
7. Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, Iwamoto Y, Yoshizaki K, Kishimoto T, Toyama Y, Okano H. Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res 2004, 76:265-276. 10.1002/jnr.20044, 15048924.
8. Mukaino M, Nakamura M, Yamada O, Okada S, Morikawa S, Renault-Mihara F, Iwanami A, Ikegami T, Ohsugi Y, Tsuji O, Katoh H, Matsuzaki Y, Toyama Y, Liu M, Okano H. Anti-IL-6-receptor antibody promotes repair of spinal cord injury by inducing microglia-dominant inflammation. Exp Neurol 2010, 224:403-414. 10.1016/j.expneurol.2010.04.020, 20478301.
9. Lacroix S, Chang L, Rose-John S, Tuszynski MH. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J Comp Neurol 2002, 454:213-228. 10.1002/cne.10407, 12442313.
10. Kerr BJ, Patterson PH. Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 2005, 51:73-79. 10.1002/glia.20177, 15779090.
11. Kerr BJ, Patterson PH. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 2004, 188:391-407. 10.1016/j.expneurol.2004.04.012, 15246839.
12. Azari MF, Profyris C, Karnezis T, Bernard CC, Small DH, Cheema SS, Ozturk E, Hatzinisiriou I, Petratos S. Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol 2006, 65(9):914-929. 10.1097/01.jnen.0000235855.77716.25, 16957585.
13. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006, 12:829-834. 10.1038/nm1425, 16783372.
14. Hermann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008, 28:7231-7243. 10.1523/JNEUROSCI.1709-08.2008, 2583788, 18614693.
15. Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ. Hematopoetic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 1999, 13:1307-1315. 10.1038/sj.leu.2401514, 10482979.
16. Gurfein BK, Zhang Y, López CB, Argaw AT, Zameer A, Moran TM, John GR. IL-11 regulates autoimmune demyelination. J Immunol 2009, 183:4229-4240. 10.4049/jimmunol.0900622, 3027139, 19734214.
17. Zhang Y, Taveggia C, Melendez-Vasquez C, Einheber S, Raine CS, Salzer JL, Brosnan CF, John GR. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J Neurosci 2006, 26:12174-12185. 10.1523/JNEUROSCI.2289-06.2006, 17122042.
18. Casha S, Yu WR, Fehlings MG. FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 2001, 196:390-400.
19. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: part 1. Clip design, behavioral outcomes and histopathology. J Neurotrauma 2002, 19:175-190. 10.1089/08977150252806947, 11893021.
20. Joshi M, Fehlings MG. Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: part 2. Quantitative neuroanatomical assessment and analysis of the relationships between axonal tracts, residual tissue, and locomotor recovery. J Neurotrauma 2002, 19:191-203. 10.1089/08977150252806956, 11893022.
21. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006, 23:635-659. 10.1089/neu.2006.23.635, 16689667.
22. Hamers FPT, Koopmans GC, Joosten EAJ. CatWalk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 2006, 23:537-548. 10.1089/neu.2006.23.537, 16629635.
23. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388. 10.1016/j.expneurol.2007.06.009, 2692462, 17662717.
24. Zhu Z, Lee CG, Zheng T, Chupp G, Wang J, Homer RJ, Noble PW, Hamid Q, Elias JA. Airway inflammation and remodeling in asthma. Am J Respire Crit Care Med 2001, 164:S67-S70.
25. Ropeleski MJ, Tang J, Walsh-Reitz MM, Musch MW, Chang EB. Interleukin-11-induced heat shock protein 25 confers intestinal epithelial-specific cytoprotection from oxidant stress. Gastroenterology 2003, 124:1358-1368. 10.1016/S0016-5085(03)00282-8, 12730876.
26. Shimizu K, Shiratori K, Sawada T, Kobayashi M, Hayashi N, Saotome H, Keith JC. Recombinant human interleukin-11 decreases severity of acute necrotizing pancreatitis in mice. Pancreas 2000, 21:134-140. 10.1097/00006676-200008000-00005, 10975706.
27. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003, 374:1-20. 10.1042/BJ20030407, 1223585, 12773095.
28. Pineau I, Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 2007, 500:267-285. 10.1002/cne.21149, 17111361.
29. Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996, 157:3627-3634.
30. Zang DW, Cheema SS. Leukemia inhibitory factor promotes recovery of locomotor function following spinal cord injury in the mouse. J Neurotrauma 2003, 20:1215-1222. 10.1089/089771503770802880, 14651808.
31. Schwab M, Tuszynski MH. Mutant mice challenged as models of injury in the central nervous system. Nat Med 2010, 16:860.